Molecular Biology of Aging

Erscheinungsjahr 2017
ISBN: 978-0-12-811532-9
Verlag: William Andrew Publishing

Buch, Englisch, 392 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 770 g

Molecular Biology of Aging, the latest volume in the Progress in Molecular Biology and Translational Science series, focuses on placental development and disease.

Zielgruppe

Students, researchers, microbiologists, molecular biologists

Autoren/Hrsg.

Weitere Mitwirkende

Reddy, P. Hemachandra

Fachgebiete

• Naturwissenschaften Biowissenschaften Mikrobiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Wachstum, Entwicklung, Altern
• Naturwissenschaften Biowissenschaften Molekularbiologie

Inhaltsverzeichnis

1. Clinical Aspects of Glucose Metabolism and Chronic Disease 2. Therapeutic Strategies for Mitochondrial Dysfunction and Oxidative Stress in Age-Related Metabolic Disorders 3. MicroRNAs as Peripheral Biomarkers in Aging and Age-Related Diseases 4. Molecular Links and Biomarkers of Stroke, Vascular Dementia, and Alzheimer's Disease 5. MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease 6. Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease 7. Mitochondrial-Targeted Catalase: Extended Longevity and the Roles in Various Disease Models 8. Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease 9. Mitochondria, Cybrids, Aging, and Alzheimer's Disease 10. The Kidney in Aging: Physiological Changes and Pathological Implications 11. Mitochondrial Perturbation in Alzheimer's Disease and Diabetes

Über Autor(innen)

Reddy, P. Hemachandra
Dr. Reddy is a tenured Professor and Vice Chair of Basic and Translational Research for the Department of Internal Medicine at Texas Tech University Health Sciences Center. He is also a Professor of Neuroscience/Pharmacology, Neurology, Public Health and Speech, and Language and Hearing Departments. His research lab has been involved with research on healthy aging, dementia, and other neurodegenerative diseases, including Huntington's, Parkinson's, and multiple sclerosis. In addition, the Reddy lab group is actively working on chronic conditions such as diabetes, obesity, cardiovascular, kidney, stroke, vascular dementia, and other factors associated with dementia. Dr. Reddy is a prolific writer, author, or co-author of more than 237 peer-reviewed articles/chapters/reviews, including publications in such journals as Nature Genetics, Ageing Research Reviews, Redox Biology, Trends in Neurosciences, Trends in Molecular Medicine, Drug Discovery Today, Human Molecular Genetics, and BBA Molecular Basis of Disease. He has received research funding from the National Institutes of Health since 2002. He also serves as Chief Scientific Officer for the Lubbock-based small business company, abSynapTEX, LLC.